AQST Aquestive Therapeutics: Net Sales Margin

Public company logo of Aquestive Pharma (AQST)

Aquestive Therapeutics (AQST) relies on professional management and robust patent protection. Net profit margin reflects efficiency dynamics, with the current level standing at -162.30. Scaling up the production of therapeutic films reduces costs, while outsourcing manufacturing and logistics to third-party contractors optimizes the global distribution of drugs.

aquestive.com (AQST) Company Sales Margin: for the period 07/04/2022 - 11/20/2026

Summary analytical data breakdowns for Aquestive Therapeutics (AQST)

- share price and consensus valuation forecast:
Fundamental valuation:Aquestive Corp - AQST
Flagship merchandise of Aquestive Corp

Analyzing fundamental risks through the sales efficiency ratio relative to net income allows for a rapid assessment of business resilience, determining whether a decline in profitability is a temporary factor or a systemic crisis. For Aquestive Therapeutics (AQST), this metric reflects the ability to monetize innovative drug delivery methods and the successful launch of adrenaline films, demonstrating the actual profitability of each unit of revenue under FDA regulatory requirements.

Analysis of competing companies

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|scPharmaceuticals, Inc. - Return on Sales by Net Profit|Net Profit Rate TECX|tonixpharma.com - Net Sales Margin|Net Profit Rate SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Net Margin|Return on Sales by Net Profit BioHarvest|Return on Sales by Net Profit EXOZ|Return on Sales by Net Profit Oramed Pharmaceuticals (ORMP)|Return on Sales by Net Profit ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma